Nicotinamide Promotes Cell Survival and Differentiation as Kinase Inhibitor in Human Pluripotent Stem Cells

Stem Cell Reports. 2018 Dec 11;11(6):1347-1356. doi: 10.1016/j.stemcr.2018.10.023. Epub 2018 Nov 29.

Abstract

Nicotinamide, the amide form of vitamin B3, is widely used in disease treatments and stem cell applications. However, nicotinamide's impact often cannot be attributed to its nutritional functions. In a vitamin screen, we find that nicotinamide promotes cell survival and differentiation in human pluripotent stem cells. Nicotinamide inhibits the phosphorylation of myosin light chain, suppresses actomyosin contraction, and leads to improved cell survival after individualization. Further analysis demonstrates that nicotinamide is an inhibitor of multiple kinases, including ROCK and casein kinase 1. We demonstrate that nicotinamide affects human embryonic stem cell pluripotency and differentiation as a selective kinase inhibitor. The findings in this report may help researchers design better strategies to develop nicotinamide-related stem cell applications and disease treatments.

Keywords: cell differentiation; cell survival; human pluripotent stem cell; kinase inhibitor; nicotinamide.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actomyosin / metabolism
  • Casein Kinase I / metabolism
  • Cell Differentiation / drug effects*
  • Cell Survival / drug effects
  • Human Embryonic Stem Cells / cytology
  • Human Embryonic Stem Cells / drug effects
  • Human Embryonic Stem Cells / metabolism
  • Humans
  • NAD / metabolism
  • Niacinamide / pharmacology*
  • Pluripotent Stem Cells / cytology*
  • Pluripotent Stem Cells / drug effects
  • Pluripotent Stem Cells / enzymology
  • Pluripotent Stem Cells / metabolism
  • Protein Kinase Inhibitors / pharmacology*
  • rho-Associated Kinases / metabolism

Substances

  • Protein Kinase Inhibitors
  • NAD
  • Niacinamide
  • Actomyosin
  • Casein Kinase I
  • rho-Associated Kinases